CellVec Pte Ltd
CellVec has been an intrinsic part of gene therapy manufacturing breakthroughs in the past and we envisage a brighter future with our meaningful involvement.
CellVec was founded in 2018 as a subsidiary of TalkMed Group, the premier provider of medical oncology and palliative care in Asia. However, our collective roots run deeper, going back to some of the first viral vectors manufactured for gene therapy. We are proud that our team members have played a central role in the evolution of this technology from a bold vision to a potentially life-transforming reality.
Today, we carry forward the legacy, rigor of scientific curiosity, discovery and commitment to Innovation for Patient Benefit.